A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Fondazione Italiana Linfomi - ETS
Alpha Tau Medical LTD.
Biogen
Stanford University
Melanoma and Skin Cancer Trials Limited
BeiGene
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Atara Biotherapeutics
Roswell Park Cancer Institute
Peter MacCallum Cancer Centre, Australia
University of Kansas Medical Center
Jonsson Comprehensive Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Novartis
Incyte Corporation
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University of Chicago
Wake Forest University Health Sciences
OHSU Knight Cancer Institute
University of Pittsburgh
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Louisville
Vanderbilt University Medical Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Morphotek
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Bristol-Myers Squibb
City of Hope Medical Center